1[1]Shimaoka Y, Hidaka Y, Okumura M ,et al. Serum con- centration of soluble Fas in patients with autoimmune thyroid diseases. Thyroid,1998,8(1) ∶ 43- 47.
3[3]Kawakami A, Eguohi K, Matsuoka N, et al. Modulation of Fasomediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves disease (GD) and idiopathic myxoedema. Clin Exp Immunol,1997,110∶ 434- 439.
4[4]Ozenirler S, Tuncer C, Boztepe U, et al. Porpylthiou- racil-induced hepatic damage.Ann Pharmacother,1996,30(9)∶ 960- 963.
9Glaser NS,Styne DM.Predicting the likelihood of remission in children with Graves disease:aprospective,multicenter study[J].Pedictrias,2008,121 (3):481.
10Read CH Jr, Tansey M J, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves patients[J]. Clin Endocrino Metab,2004,89(9):4229.
